Dr. Nisha Hariharan
Qualifications: HBNI Tata Fellowship (Breast Oncology), MS.
Areas of Specialization:
Dr. Nisha Hariharan is a Consultant, Breast Onco-surgeon, with over a decade of experience, specializing in conservative breast surgeries and sentinel node biopsies.
Dr. Nisha received her degree in Surgery from Grant Medical College and Sir. J. J. Group of Hospitals, Mumbai. She then trained at Tata Memorial Hospital, successfully completing her certified HBNI Fellowship in Breast Oncology. She has previously held positions at S.L Raheja Hospital and Apollo Hospitals, Mumbai.
Dr. Nisha has dedicated her practice to breast cancer, focussing on cosmetic and conservative breast cancer surgeries and sentinel node biopsies. Other areas of expertise include benign breast lumps, pregnancy-associated breast tumours, cancers in women with genetic predisposition or family history, bilateral breast cancers and screening procedures among older or high-risk women. She has given multiple talks at conferences including the Indian Cancer Congress and has presented her work at various international conferences at Singapore, Belgium, etc. She is trained in clinical research and data analysis and has been the Lead and Co-Investigator in several national and international clinical trials.
She enjoys interactive sessions and often holds live discussions and counseling on breast self-examination/early detection of breast lumps with women across different demographics in her free time.
ASI (Association of Surgeons of India)
IASO (Indian Association of Surgical Oncologists)
ABSI (Association of Breast Surgeons of India)
BCN (Breast Centres Network, Europe)
ESSO (European Society of Surgical Oncology)
ESMO (European Society of Medical Oncology)
Certificates and Achievements:
Certification in Biostatistics in association with the University of North Carolina (2015)
Awarded Best Paper Presentation at Indian Cancer Congress 2017, Bangalore, India
Managing victims of the terrorist attack in Mumbai on 26th Nov 2008.
Precision medicine – A new era in multidisciplinary care Cancer Treat Res Commun. 2022;32:100577. doi:10.1016/j.ctarc.2022.100577
Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with complete/near complete clinical and radiologic response (Complete Responders in the Breast- CRBr)- Trial design and conduct. Intl J of Surg Protocols 16(2019) 5-8
The evolving role of pathologic complete response in breast cancer. South Asian J Cancer 2019;8:210-1.
The impact of stage and molecular subtypes on survival outcomes in young women with breast cancer. Journal of Adolescent and Young Adult Oncology Oct 2019, 628-634
Survival outcomes in male breast cancer – A single institution experience Asian Pac J Cancer Care, 3(4), 71-74, doi:10.22034/APJCC.2018.3.4.71
Intersectoral tuberculous lymphadenitis masquerading as carcinoma breast: A case report. Indian J Case Reports. 2017;3(4):224-226.
Demographic Profile and Prevalence of Comorbidities in newly diagnosed women with breast cancer: Experience from a tertiary care institute. Ann Clin Lab Res Vol. 6 No. 4:270
Contributing author for the chapter on breast cancer in “A Textbook of Oncology in the Indian Context” published in March 2019